Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-09-12 00:00:00 ET · period of report 2022-09-08 · accession 0001883850-22-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-12 | 2022-09-08+ | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $704.65 | -3,167 | 1,082 | -75% | -$2.23M |
| DM | 2022-09-12 | 2022-09-08+ | REGN | Bassler Bonnie L | Dir | M - OptEx | $388.99 | +3,167 | 2,361 | New | +$1.23M |
| DM | 2022-09-12 | 2022-09-08+ | REGN | Bassler Bonnie L | Dir | M - OptEx | $0.00 | -3,167 | 3,839 | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-08 | S | D | 1,279 | $686.99 | 1,082 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-08 | S | D | 1,279 | $705.00 | 1,082 | D | — | — | (F2) Represents volume-weighted average price of sales of 1,279 shares of Company stock on September 8, 2022 at prices ranging from $705.00 to $705.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 8, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-09-09 | M | A | 609 | $376.69 | 1,691 | D | — | — | |
| 4 | Common | Common Stock | 2022-09-08 | M | A | 1,279 | $391.92 | 2,361 | D | — | — | |
| 5 | Common | Common Stock | 2022-09-09 | S | D | 609 | $741.00 | 1,082 | D | — | — | |
| 6 | Common | Common Stock | 2022-09-08 | M | A | 1,279 | $391.92 | 2,361 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-09-09 | M | D | 609 | $0.00 | 610 | D | $376.69 · — to 2027-01-03 | 609 Common Stock | (F3) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-09-08 | M | D | 1,279 | $0.00 | 2,560 | D | $391.92 · — to 2026-09-09 | 1,279 Common Stock | (F3) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-09-08 | M | D | 1,279 | $0.00 | 3,839 | D | $391.92 · — to 2026-09-09 | 1,279 Common Stock | (F3) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |